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Infectious Diseases Service, CHUV, Lausanne, 
Switzerland 
Background: The pro-inflammatory c tokine MIF is 
an important effector moLecuLe of innate immunity 
and inflammation. Two functional potymorphisms of 
the MIF promoter, a 5 to 8 CATT tetranucteotide 
repeat at -794 (-794 CATTS-8) and a G/C single 
nucteotide potymorphism at-173 (-173"G/C SNP), 
have been associated with susceptibility to and/or 
severity of rheumatoid arthritis, atopy, colitis and 
erythema nodosum in sarcoidosis. CircuLating MIF 
LeveLs are elevated in patients with tuberculosis. 
Moreover, MIF has been shown to restrict he intra- 
ceLLuLar growth of virulent Mycobacterium tuber- 
culosis in macrophages. 
Objective: To study whether MIF gene potymor- 
phisms were associated with susceptibility to or 
severity of tuberculosis (TB) and to analyse the 
functional and bioLogicaL effects of MIF potymor- 
phisms in vitro. Methods: Case control study in- 
cluding healthy Mantoux positive adults, healthy 
Mantoux positive and negative children and chiL- 
dren with active TB from 2 South African popu- 
Lations: the Xhosa (bLack) and the Cape co[oured 
(descendants from a mixed population of im- 
ported slaves). -794 CATT5-8 microsatettite and 
-173"G/C SNP were detected by high-resoLution 
get-etectrophoresis and TaqMan ® SNP Genotyping 
Assay, respectively. The most frequently occurring 
MIF promoter (-1073/+129) aLLeLes were cloned into 
a [uciferase reporter vector and transfected into 
human THP-1 monocytic eLLs. 
Results: The frequency of the CATT6-6 genotype 
was decreased in Xhosa and Cape co[oured TB 
patients. Furthermore, the-794 CATT6-6 geno- 
type was reduced in Cape Co[oured with extra- 
pulmonary TB. In vitro experiments revealed an 
increased MIF CATT6-promoter transcriptional c- 
tivity in resting THP-1. There was no association 
http://intL e[sevierhea[th.com/journa[s/ijid 
between the-173"G/C SNP and the susceptibility 
or severity of tuberculosis. 
Conclusions: We observed reduced CATT6 aLLeLe 
and genotype frequencies in Xhosa and Cape CoL- 
ored TB patients and an increased MIF CATT6- 
promoter transcriptional activity in vitro. We pos- 
tulate that carriers of the MIF CATT6 aLLeLe may 
have higher MIF LeveLs which may help to contain 
Mycobacterium tuberculosis growth, resulting in 
improved host defense against Mycobacterium tu- 
berculosis. 
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Macropha,~le Mi,~Iration Inhibitory Factor Plays 
an Important Role in the Host Innate Immune 
Defenses a~lainst Candida Infection 
C. Nico[o*, D. Le Roy, M.K. Reymond, T. Roger, 
T. Catandra. InJ:ectious Diseases, CHUV, Lausanne, 
Switzerland 
Background: Invasive candidiasis has emerged 
worldwide as an increasingly frequent cause of 
opportunistic infections in criticaLLy it[ and im- 
munocompromised patients that are associated 
with high morbidity and mortality. The balance 
between pro-inflammatory (IFNy and IL-12) and 
anti-inflammatory (IL-10) cytokines is a key de- 
terminant of the outcome of Candida infections. 
Macrophage migration inhibitory factor (MIF), a 
pro-inflammatory cytokine, is an important effec- 
tor moLecuLe of innate immunity and has been 
shown to play a central rote in the pathogenesis 
of bacterial sepsis. 
Objective: To study the rote of MIF in the patho- 
genesis of invasive candidiasis. 
Methods: BALB/c mice were injected with anti- 
MIF or control IgG antibodies (2 mg i.p/mouse) 30 
minutes before an I.V. injection of 3.5-5×10 sCFU 
of a cLinicaL isolate of C. albicans. MIF, IFNy, IL-12 
and IL-IO LeveLs and fungat Loads were measured in 
blood, spleen and kidney 1, 2, 3, 5 and 9 days post- 
infection. Body weight and survival were foLLowed 
daily. 
Results: After intravenous injection, C. albicans 
was rapidly cleared from the circulation and pref- 
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erentia[[y infected the kidney. Development of re- 
nal candidiasis was accompanied by a substantial 
decrease of MIF (day 0: 37.5+4.2pg/g; day 9: 
19=l=4.7pg/g, P =0.002), IFN? (day 0: 5.9=1=1.4 ng/g; 
day 9: 3.5=l=1.4ng/g, P=0.002), IL-12 (day 0: 
43.4=l=6.7ng/g; day 9: 19.6=l=11.8ng/g, P=0.009), 
and IL-10 (day 0: 8.3+2.7ng/g; day 9:3.8+3 ng/g, 
P =0.06) concentrations in the kidney. Neutraliza- 
tion of MIF activity with anti-MIF IgG decreased 
the pro-inflammatory response in the kidney, as 
shown by a reduction of IL-12/IL-10 (P =0.002) and 
of IFN?/IL-10 (P=0.001) ratios at day 5. Moreover, 
treatment of mice with anti-MIF IgG markedly in- 
creased mortality of invasive candidiasis (from 40% 
in control IgG treated mice to 73% in anti-MIF IgG 
treated mice, P=0.02). 
Conclusion: Neutralizing MIF activity impairs the 
host pro-inflammatory innate immune response and 
augment lethality of invasive candidiasis. Thus, 
these data identify MIF as an important effec- 
tor molecule of the host innate immune defenses 
against Candida infection. 
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Structure Specific Inflammatory Activity of 
Peptidoglycan (PG) Stem Peptides 
P.A. Majcherczyk*, L. Decrausaz, B. Guignard, 
B. Berger-Baechi, R Morei[[on. Department o[ 
Fundamental Microbiology University o[ Lausanne, 
1015 Lausanne, Switzerland 
Background: PG is a complex macromo[ecu[e com- 
posed of g[ycan chains to which stem peptides 
are attached. It is reputed to trigger cytokine 
release (eg TNF) from macrophages and other re- 
sponsive ceils. Recently we showed that PG from 
S. pneumoniae (Sp) contained inactive mono- and 
dimeric stem peptides and inflammatory trimeric 
stem peptides. However, trimeric stem peptides 
purified from S. aureus (Sa) were inactive. These 
were cross[inked via 5 g[ycines whereas those in 
Sp were cross[inked directly or only via 2 a[anines. 
The difference in the length of the stem peptide 
cross[ink in these species might explain the diver- 
gence of their inflammatory activity. This hypothe- 
sis was tested with stem peptides purified from Sa 
FEM mutants with different sized cross[inks. 
Methods: Lipoteichoic acid-free PG was purified 
from Sp 8: Sa (cross[ink via 1, 3 or 5 g[yines), so[ubi[- 
ised by auto[ysins and separated by HPLC. Mono-, 
di- and trimeric stem peptides were identified by 
mass spectrometry. Stimu[atory activity was tested 
by incubating them with human blood in triplicate 
for 8h at 37°C + po[ymixin (pmx) on 3 separate 
days. TNF released was quantified by bioassay. 
Results: Insoluble PG from Sa~tSp induced TNF 
(1000 pg/m[) at 10ug/m[. Mono- and dimeric stem 
peptides from both species were inactive at this 
concentration. Trimers purified from Sa mutants 
cross[inked via 1, 3 or 5 g[ycines were also inactive, 
whereas trimers from Sp were active at 0.1 ug/m[. 
Pmx did not inhibit this activation. 
Conclusions: Inflammatory activity of the insolu- 
ble PG and inactivity of their isolated mono- and 
dipeptides suggest that a minimum po[ymerisation 
of the stem peptides is required for activation. 
The po[ymerisation must yield a structure of spe- 
cific size and conformation to be active. Active 
trimers from Sp had such an optimum conformation 
whereas those of the Sa mutants with different 
cross[inks were inactive. Inflammatory activity of 
PG stem peptides is thus structure specific. It de- 
pends on their po[ymerisation, nature and compo- 
sition of their cross[ink. 
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Transcriptional and Post-transcriptional 
Regulation of Human MIF Gene Expression 
T. Roger*, X. Ding, A-L. Chanson, P. Renner, 
T. Ca[andra. In[ectious Diseases Service, CHUV, 
Lausanne, Switzerland 
Background: The cytokine macrophage migration 
inhibitory factor (MIF) is an important regulator 
of innate immunity, inflammation and oncogenesis. 
MIF promoter po[ymorphisms have been associated 
with susceptibility to and/or severity of rheuma- 
toid arthritis, atopia and ulcerative colitis. Yet, the 
molecular mechanisms regulating the expression of 
the MIF gene remain largely unknown. 
Objective: To elucidate the transcriptional and 
post-transcriptional regulation of MIF. 
Methods: Experiments were performed with hu- 
man PBMCs, THP-1 monocytic ceils, HeLa and A549 
epithelial ceils and HaCat keratinocytes, murine 
macrophages and insect Sf9 ceils. MIF mRNA, pro- 
tein and promoter activities were assessed by 
Northern blotting, Western blotting and [uciferase 
reporter assay, respectively. Transcription factor 
binding activity was assessed by EMSA, supershift 
and chromatin immunoprecipitation (CHIP). Ge- 
nomic DNA methy[ation was assessed by sodium 
bisu[fite sequencing. 
Results: Several potential regulatory sequences 
were identified within a 2.8 kb fragment upstream 
of the transcription start site. Spl and CRE binding 
sites in the proximal MIF promoter were required 
for fuji MIF promoter activity. EMSA, supershifts 
and ChIP analyses showed that Spl and CREB tran- 
scription factors bound to the proximal Spl and 
